Skye BioscienceSKYE
13F holders, Q2 2026 (June 30)42holders +3
6new positions
3sold out
1famous investor
$0.69avg. 13F price*
At the end of Q2 2026, 42 institutions reported holding Skye Bioscience Inc. (SKYE) in their 13F filings, up 3 from Q1 2026. 6 opened new positions and 3 sold out. The largest holders were 5AM Venture Management, LLC ($6.7M), Versant Venture Management, LLC ($1.4M) and Baker Bros. Advisors LP ($1.1M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Skye Bioscience Inc.
- CUSIP
- 83086J200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $49K |
| Exits | 3 | $16K |
All 13F filers, Q1 2026 → Q2 2026: 134,295 shares bought and 241,140 shares sold, net −106,845 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 42 holders
| 5AM Venture Management, LLC | 2.33% | No change | 9,681,763 | $6.7M |
| Versant Venture Management, LLC | 0.86% | No change | 2,007,704 | $1.4M |
| Baker Bros. Advisors LP | 0.01% | No change | 1,575,243 | $1.1M |
| Vanguard Capital Management LLC | 0.00% | Reduce -0.1% | 763,882 | $529K |
| Sphera Funds Management LTD. | 0.07% | No change | 678,928 | $471K |
| Platinum Investment Management Ltd. | 0.04% | No change | 233,095 | $162K |
| BlackRock, Inc. | 0.00% | Reduce -18.6% | 232,874 | $161K |
| Geode Capital Management, LLC | 0.00% | Reduce -21.4% | 218,055 | $151K |
| Millennium Management | 0.00% | Reduce -23.1% | 198,524 | $138K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 104,229 | $72K |
| State Street Corp. | 0.00% | Reduce -2.0% | 73,830 | $51K |
| UBS Group AG | 0.00% | Add +61.3% | 73,800 | $51K |
| Northern Trust Corp. | 0.00% | Add +179.7% | 56,327 | $39K |
| Qube Research & Technologies Ltd | 0.00% | New | 43,082 | $30K |
| Simplex Trading, LLC | 0.00% | New | 26,976 | $19K |
| XTX Topco Ltd | 0.00% | Reduce -48.7% | 20,993 | $15K |
| Engineers Gate Manager LP | 0.00% | No change | 20,194 | $14K |
| Group One Trading LLC | 0.00% | Reduce -36.3% | 4,589 | $3K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 4,557 | $3K |
| Morgan Stanley | 0.00% | Reduce -3.1% | 2,469 | $2K |
| Barclays PLC | 0.00% | Reduce -96.4% | 655 | $455 |
| Osaic Holdings, Inc. | 0.00% | No change | 600 | $413 |
| National Bank of Canada | 0.00% | No change | 400 | $275 |
| JPMorgan Chase & Co. | 0.00% | No change | 66 | $44 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | No change | 52 | $36 |
| TD Waterhouse Canada Inc. | 0.00% | Reduce -34.2% | 52 | $35 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 51 | $35 |
| Rockefeller Capital Management L.P. | 0.00% | No change | 39 | $27 |
| Optiver Holding B.V. | 0.00% | No change | 20 | $14 |
| CoreCap Advisors, LLC | 0.00% | No change | 8 | $6 |
| Jones Financial Companies LLLP | 0.00% | New | 8 | $5 |
| Gilpin Wealth Management, LLC | 0.00% | New | 4 | $3 |
| Plante Moran Financial Advisors, LLC | 0.00% | No change | 3 | $2 |
| Wells Fargo & Company | 0.00% | New | 1 | $1 |
| FMR LLC | 0.00% | New | 1 | $1 |
| Harbour Investments, Inc. | 0.00% | No change | 1 | $1 |
| IFP Advisors, Inc | 0.00% | Reduce -50.0% | 1 | $1 |
| NFSG Corp | 0.00% | No change | 1 | $1 |
| Leo H. Evart, Inc. | 0.00% | No change | 1 | $1 |
| PFS Partners, LLC | 0.00% | No change | 1 | $1 |
| McGuire Capital Advisors Inc. | 0.00% | No change | 2 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -5.5% | 120 | $0 |
"% of holder's portfolio" is SKYE's weight in each manager's 13F, not the share of Skye Bioscience Inc. the manager owns.